New Filings & Updated Terms (Week Ending 06.12.20am)

Company: Dun & Bradstreet Holdings, Inc.
Symbol: DNB
Description: Dun & Bradstreet is a leading global provider of business decisioning data and analytics.
Shares: TBD
Price Range: TBD
Market Cap: TBD
Trade Date: TBD
Underwriter(s): Goldman Sachs, BofA Securities, J.P. Morgan, Barclays
Filed: 6-9-20
Listed Cash Raise: $1bn

Company: Lemonade, Inc.
Symbol: LMND
Description: Lemonade is rebuilding insurance from the ground up on a digital substrate and an innovative business model.
Shares: TBD
Price Range: TBD
Market Cap: TBD
Trade Date: TBD
Underwriter(s): Goldman Sachs, Morgan Stanley, Allen & Co., Barclays
Co-Manger(s): JMP Securities, Oppenheimer, William Blair, LionTree
Filed : 6-8-20

Company: Agora Inc.
Symbol: API
Description: They pioneered Real-Time Engagement Platform-as-a-Service, or RTE-PaaS, and they are the global leader by market share in this rapidly growing industry.
Shares: TBD
Price Range: TBD
Market Cap: TBD
Trade Date: TBD
Underwriter(s): Morgan Stanley, BofA Securities
Filed: 6-5-20
Listed Cash Raise: $100m

Company: Fusion Pharmaceuticals Inc.
Symbol: FUSN
Description: They are a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines.
Shares: TBD
Price Range: TBD
Market Cap: TBD
Trade Date: TBD
Underwriter(s): Morgan Stanley, Jefferies, Cowen
Co-Manager: Wedbush PacGrow
Filed: 6-5-20
Listed Cash Raise: $100m

Company: PolyPid Ltd.
Symbol: PYPD
Description: They are a Phase 3 clinical-stage biopharmaceutical company focused on developing targeted, locally administered and prolonged-release therapeutics using our proprietary Polymer-Lipid Encapsulation matriX, or PLEX, technology.
Shares: TBD
Price Range: TBD
Market Cap: TBD
Trade Date: TBD
Underwriter(s): Barclays, BMO Capital
Co-Manager: Raymond James, National Securities, AGP
Filed: 6-5-20
Listed Cash Raise: $57.5m
Last Postponed in March 2018

Company: Akouos, Inc.
Symbol: AKUS
Description: They are a precision genetic medicine company dedicated to our mission of developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for people worldwide who live with disabling hearing loss.
Shares: TBD
Price Range: TBD
Market Cap: TBD
Trade Date: TBD
Underwriter(s): BofA Securities, Cowen, Piper Sandler
Filed: 6-5-20
Listed Cash Raise: $100m

Company: ArcherDx, Inc.
Symbol: RCHR
Description: They are a leading genomics company democratizing precision oncology.
Shares: TBD
Price Range: TBD
Market Cap: TBD
Trade Date: TBD
Underwriter(s): JP Morgan, BofA Securities, Stifel, Evercore ISI
Filed: 6-5-20
Listed Cash Raise: $100m

TERMS ADDED

Company: Royalty Pharma plc
Symbol: RPRX
Description: They are the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry.
Shares: 70 million
Price Range: $25.00-$28.00
Market Cap: $14.9b-$16.7b
Trade Date: Tuesday, 6/16
Underwriter(s): JP Morgan, Morgan Stanley, BofA Securities, Goldman Sachs, Citigroup, UBS, Evercore ISI, Cowen, SunTrust Robinson Humphrey
Co-Manager: BBVA, DNB Markets, Scotiabank, TD Securities
Terms Added: 6-8-20